Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Advanced Enzyme Technologies Limited Regulatory Filings 2020

Dec 31, 2020

62369_rns_2020-12-31_3e8e4605-94fb-4fcf-82ff-bed42dd616a4.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

December 31, 2020

BSE Limited Department of Corporate Affairs P. J. Towers, Dalal Street, Mumbai-400 001 Scrip ID-540025

National Stock Exchange of India Ltd. Exchange Plaza, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai-400 051 Scrip Code-ADVENZYMES

Dear Sir/Madam,

Sub: Intimation of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

We wish to inform you that pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of Analyst / Institutional Investor Meeting with the Company is as under:

Date Interaction With Type & details
December 31, 2020 ICICI Prudential MF Virtual meetingat 4 p.m.,One to One

Note: The schedule is subject to change. Changes may happen due to exigencies on the part of Fund/Company.

The aforesaid information is also being uploaded on the Company’s website.

You are requested to kindly take a note of the same.

Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited

SANJAY Digitally signed by SANJAY PRAKASH PRAKASH BASANTANI BASANTANI Date: 2020.12.31 09:59:02 +05'30'


Sanjay Basantani Company Secretary and Head – Legal